Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydrocortisone butyrate
Drug ID BADD_D01088
Description Not Available
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
Marketing Status approved; vet_approved
ATC Code D07AB02
DrugBank ID DB14540
KEGG ID D01619
MeSH ID C007975
PubChem ID 26133
TTD Drug ID Not Available
NDC Product Code 51672-4061; 68682-271; 16781-384; 68180-951; 65089-0035; 68462-464; 68682-384; 52128-130; 68682-392; 82160-127; 16781-392; 64958-0030; 51672-4074; 51672-4083
UNII 05RMF7YPWN
Synonyms hydrocortisone-17-butyrate | hydrocortisone 17-butyrate | hydrocortisone butyrate | cortisol 17-butyrate | Locoid
Chemical Information
Molecular Formula C25H36O6
CAS Registry Number 13609-67-1
SMILES CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cataract06.06.01.001--
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Dry skin23.03.03.001--
Folliculitis23.11.04.003; 11.02.01.053--
Hypersensitivity10.01.03.003--
Hypertrichosis23.02.04.002--
Infection11.01.08.002--Not Available
Intraocular pressure increased13.07.04.002--Not Available
Irritability19.04.02.013; 08.01.03.011--
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Pain08.01.08.004--
Pruritus23.03.12.001--
Purpura24.07.06.005; 23.06.01.004; 01.01.04.003--
Rebound effect08.06.02.009--Not Available
Rosacea23.02.08.001--Not Available
Skin atrophy23.01.05.001--
Skin hypopigmentation23.05.02.003--
Skin striae23.01.05.002--Not Available
Telangiectasia23.06.03.001; 24.03.03.003--
Vascular purpura23.06.01.008; 01.01.04.007; 24.07.06.011--Not Available
Viral infection11.05.04.001--Not Available
Skin maceration23.03.03.016--Not Available
Nail atrophy23.02.05.010--Not Available
The 1th Page    1    Total 1 Pages